Contact this trialFirst, we need to learn more about you.
Immunotherapy
GB1275 for Esophageal Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug, GB1275, on patients with metastatic pancreatic adenocarcinoma (cancer that has spread from the pancreas) or other specified metastatic solid tumors. The trial has two phases: 1) a dose escalation/expansion phase to test safety and effectiveness, and 2) a basket expansion phase to test effectiveness in different types of tumors.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.